NDC 66435-101

Ribasphere

Ribavirin

Ribasphere is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Kadmon Pharmaceuticals, Llc. The primary component is Ribavirin.

Product ID66435-101_3e2fab44-f5d6-4d48-b534-f3f86309f358
NDC66435-101
Product TypeHuman Prescription Drug
Proprietary NameRibasphere
Generic NameRibavirin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2004-04-07
Marketing CategoryANDA / ANDA
Application NumberANDA076203
Labeler NameKadmon Pharmaceuticals, LLC
Substance NameRIBAVIRIN
Active Ingredient Strength200 mg/1
Pharm ClassesNucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 66435-101-18

180 CAPSULE in 1 BOTTLE, PLASTIC (66435-101-18)
Marketing Start Date2004-04-07
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 66435-101-56 [66435010156]

Ribasphere CAPSULE
Marketing CategoryANDA
Application NumberANDA076203
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2005-10-01
Marketing End Date2016-12-01

NDC 66435-101-18 [66435010118]

Ribasphere CAPSULE
Marketing CategoryANDA
Application NumberANDA076203
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-04-07
Marketing End Date2019-09-30

NDC 66435-101-42 [66435010142]

Ribasphere CAPSULE
Marketing CategoryANDA
Application NumberANDA076203
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2005-10-01
Marketing End Date2016-12-01

NDC 66435-101-16 [66435010116]

Ribasphere CAPSULE
Marketing CategoryANDA
Application NumberANDA076203
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-11-11
Marketing End Date2004-11-12

NDC 66435-101-14 [66435010114]

Ribasphere CAPSULE
Marketing CategoryANDA
Application NumberANDA076203
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-11-11
Marketing End Date2004-11-12

NDC 66435-101-84 [66435010184]

Ribasphere CAPSULE
Marketing CategoryANDA
Application NumberANDA076203
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2005-10-01
Marketing End Date2019-09-30

NDC 66435-101-70 [66435010170]

Ribasphere CAPSULE
Marketing CategoryANDA
Application NumberANDA076203
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2005-10-01
Marketing End Date2016-12-01

Drug Details

Active Ingredients

IngredientStrength
RIBAVIRIN200 mg/1

OpenFDA Data

SPL SET ID:7dfd3fdd-efa4-4239-8cd7-ddf2de682328
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 312817
  • 539485

    • Pharmacological Class

    • Nucleoside Analog [EXT]
    • Nucleoside Analog Antiviral [EPC]

    Medicade Reported Pricing

    66435010184 RIBASPHERE 200 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    66435010170 RIBASPHERE 200 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    66435010156 RIBASPHERE 200 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    66435010142 RIBASPHERE 200 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    66435010118 RIBASPHERE 200 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Ribasphere" or generic name "Ribavirin"

    NDCBrand NameGeneric Name
    66435-102RIBASPHERERIBASPHERE
    66435-104RIBASPHERERIBASPHERE
    66435-101RibasphereRibasphere
    66435-103RIBASPHERERIBASPHERE
    0074-3197ModeribaRibavirin
    0074-3282ModeribaRibavirin
    0085-1318REBETOLribavirin
    0781-2043RibavirinRibavirin
    0781-5177RibavirinRibavirin
    42494-423RibavirinRibavirin
    53808-0781RibavirinRIBAVIRIN
    53808-0782RibavirinRIBAVIRIN
    54738-950ribavirinribavirin
    54738-951ribavirinribavirin
    54738-952ribavirinribavirin
    54738-953ribavirinribavirin
    63629-2149RibavirinRibavirin
    65841-046RibavirinRibavirin
    65841-129RibavirinRibavirin
    65841-260RibavirinRibavirin
    65841-603RibavirinRibavirin
    65841-632RibavirinRibavirin
    65862-207RibavirinRibavirin
    0187-0007VirazoleRibavirin

    Trademark Results [Ribasphere]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    RIBASPHERE
    RIBASPHERE
    76535804 2952736 Live/Registered
    KADMON CORPORATION, LLC
    2003-07-29
    RIBASPHERE
    RIBASPHERE
    76412404 2887092 Live/Registered
    KADMON CORPORATION, LLC
    2002-05-24
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.